77 filings
Page 3 of 4
8-K
6rox xzpwe
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
EFFECT
e78k9x6g
21 Mar 22
Notice of effectiveness
12:15am
CORRESP
9i0wqy4
16 Mar 22
Correspondence with SEC
12:00am
UPLOAD
izjbabd 8zojmm0zpwp
16 Mar 22
Letter from SEC
12:00am
S-3
a4on 8dq8vjz8l
14 Mar 22
Shelf registration
5:15pm
S-8
aj44pz x4kvp
14 Mar 22
Registration of securities for employees
5:12pm
8-K
6nz5ut3488
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
10-Q
3hnsp1hby7 j1pq3w
6 May 21
Quarterly report
4:02pm
10-K
e9erpa
25 Mar 21
Annual report
4:01pm
S-8
qh4doa
9 Feb 21
Registration of securities for employees
5:12pm
8-K
7sg1xcncwcjpp96v85
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
424B4
90978c ofq
8 Feb 21
Prospectus supplement with pricing info
6:07am
S-1MEF
nz0uqfkn zlqlyh3gr
5 Feb 21
Registration of additional securities for an S-1
6:06am
EFFECT
eibfnf6p9kzdy0
5 Feb 21
Notice of effectiveness
12:15am
SEC STAFF
nnf8wx
4 Feb 21
SEC staff action: Order
12:00am
CERT
zhr2z o66r5
3 Feb 21
Certification of approval for exchange listing
3:11pm
FWP
y6xvpjclx
3 Feb 21
Free writing prospectus
11:30am